News and Announcements
Cellmid Collaborates on Early Diagnosis of Colorectal Cancer
- Published July 29, 2013 9:57AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
- Cellmid signed collaboration agreement with Abcodia for testing midkine in longitudinal serum samples
- Abcodia has exclusive access to a unique collection of 5,000,000 serum samples
- Initially targeting validation of midkine as early marker of colorectal cancer
Sydney, Monday 29 July 2013: Cellmid Limited (ASX:CDY) signed a collaboration agreement with Abcodia Ltd, the UK biomaker validation company, for the testing of midkine (MK) in their collection of longitudinal serum samples using Cellmid’s MK-ELISA.
The initial objective of the collaboration to validate midkine as a useful marker for the screening and early diagnosis of colorectal cancer. Serum samples will be provided by Abcodia and testing will be carried out by Cellmid.
To read the full ASX announcement, please download the document below.
Company Updates
Built on discipline, not complexity: inside an ASX equities income strategy
Haydn Froggatt and Zac Brabin have decades of derivatives experience between them and access to almost any strategy in the market. They use two of the simplest structures available, and wrote 202 positions with them last year. Published by Fairway Capital Management. Based on an interview with co-founders Haydn Froggatt and Zac Brabin. Two traders, […]
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
Backed By Leading Investment Groups and Family Offices
